Published in PLoS Pathog on December 29, 2011
Caspase-11 protects against bacteria that escape the vacuole. Science (2013) 4.01
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology (2014) 2.22
Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β. J Exp Med (2015) 1.57
Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia. J Clin Invest (2013) 1.43
Pyroptotic cell death defends against intracellular pathogens. Immunol Rev (2015) 1.40
Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation. PLoS Pathog (2017) 1.38
The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases. Int Neurourol J (2012) 1.23
NLRC4 inflammasome-mediated production of IL-1β modulates mucosal immunity in the lung against gram-negative bacterial infection. J Immunol (2012) 1.22
Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection. Curr Opin Microbiol (2013) 1.19
Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol (2013) 1.11
Development of Burkholderia mallei and pseudomallei vaccines. Front Cell Infect Microbiol (2013) 1.08
Functions of NOD-Like Receptors in Human Diseases. Front Immunol (2013) 1.08
Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis. PLoS One (2013) 1.02
NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. Mucosal Immunol (2013) 1.01
Inflammasomes. Cold Spring Harb Perspect Biol (2014) 0.95
Canonical Inflammasomes Drive IFN-γ to Prime Caspase-11 in Defense against a Cytosol-Invasive Bacterium. Cell Host Microbe (2015) 0.92
Distinct licensing of IL-18 and IL-1β secretion in response to NLRP3 inflammasome activation. PLoS One (2012) 0.92
Programmed cell death as a defence against infection. Nat Rev Immunol (2017) 0.91
Caspase-1-dependent and -independent cell death pathways in Burkholderia pseudomallei infection of macrophages. PLoS Pathog (2014) 0.91
NLRP3 inflammasome and host protection against bacterial infection. J Korean Med Sci (2013) 0.91
Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection. Sci Rep (2013) 0.91
Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock. Infect Immun (2013) 0.90
Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages. PLoS Negl Trop Dis (2014) 0.89
Alcohol-induced liver injury is modulated by Nlrp3 and Nlrc4 inflammasomes in mice. Mediators Inflamm (2013) 0.87
Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli. Mucosal Immunol (2015) 0.85
Detection of cytosolic bacteria by inflammatory caspases. Curr Opin Microbiol (2013) 0.84
Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils. PLoS One (2012) 0.84
A balanced IL-1β activity is required for host response to Citrobacter rodentium infection. PLoS One (2013) 0.84
Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Negl Trop Dis (2013) 0.84
Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomallei. PLoS Negl Trop Dis (2013) 0.83
The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation. Front Immunol (2014) 0.83
Inflammation and pyroptosis mediate muscle expansion in an interleukin-1β (IL-1β)-dependent manner. J Biol Chem (2015) 0.82
Limited role for ASC and NLRP3 during in vivo Salmonella Typhimurium infection. BMC Immunol (2014) 0.82
Neutrophil elastase causes tissue damage that decreases host tolerance to lung infection with burkholderia species. PLoS Pathog (2014) 0.81
Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals. Cell Mol Immunol (2016) 0.81
NLRC4 and TLR5 each contribute to host defense in respiratory melioidosis. PLoS Negl Trop Dis (2014) 0.80
Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis). Intensive Care Med Exp (2014) 0.80
Therapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis. Shock (2016) 0.80
Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia. Infect Immun (2016) 0.80
Reassessing the Evolutionary Importance of Inflammasomes. J Immunol (2016) 0.80
Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental Melioidosis. PLoS Negl Trop Dis (2016) 0.79
Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species. BMC Microbiol (2015) 0.79
Programmed cell death and its role in inflammation. Mil Med Res (2015) 0.79
Protective and detrimental roles of inflammasomes in disease. Semin Immunopathol (2015) 0.79
The role of NOD2 in murine and human melioidosis. J Immunol (2013) 0.79
NLRP12 modulates host defense through IL-17A-CXCL1 axis. Mucosal Immunol (2015) 0.78
Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice. PLoS One (2014) 0.78
Divergent functions of Toll-like receptors during bacterial lung infections. Am J Respir Crit Care Med (2014) 0.77
Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages. Infect Immun (2013) 0.77
Differential ASC requirements reveal a key role for neutrophils and a noncanonical IL-1β response to Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol (2015) 0.77
HDAC8-mediated epigenetic reprogramming plays a key role in resistance to anthrax lethal toxin-induced pyroptosis in macrophages. J Immunol (2014) 0.77
A thrombomodulin mutation that impairs active protein C generation is detrimental in severe pneumonia-derived gram-negative sepsis (melioidosis). PLoS Negl Trop Dis (2014) 0.76
Rickettsia australis Activates Inflammasome in Human and Murine Macrophages. PLoS One (2016) 0.76
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev (2017) 0.75
Diabetes-independent increase of factor VII-activating protease activation in patients with Gram-negative sepsis (melioidosis). J Thromb Haemost (2014) 0.75
Piperine Suppresses Pyroptosis and Interleukin-1β Release upon ATP Triggering and Bacterial Infection. Front Pharmacol (2016) 0.75
Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells. Infect Immun (2016) 0.75
Efficient inactivation of Burkholderia pseudomallei or Francisella tularensis in infected cells for safe removal from biosafety level 3 containment laboratories. Pathog Dis (2014) 0.75
Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis. PLoS Negl Trop Dis (2017) 0.75
Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice. PLoS One (2017) 0.75
Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines. PLoS One (2017) 0.75
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature (2004) 14.80
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 14.33
Nonresolving inflammation. Cell (2010) 7.74
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med (2004) 7.49
Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature (2011) 6.38
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol (2006) 6.34
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature (2011) 6.21
Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol (2010) 6.05
The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol (2011) 5.73
Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A (2010) 5.59
Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog (2006) 5.17
Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J Exp Med (2006) 4.86
Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog (2007) 4.73
The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol (2006) 4.70
Neutrophils and acute lung injury. Crit Care Med (2003) 4.56
Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med (2010) 4.52
Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur J Immunol (2007) 4.19
Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe (2010) 4.10
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol (2010) 3.25
Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog (2006) 3.04
Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol (2008) 2.87
Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun (2001) 2.76
The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol (1998) 2.46
Asc and Ipaf Inflammasomes direct distinct pathways for caspase-1 activation in response to Legionella pneumophila. Infect Immun (2009) 2.42
Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A (1999) 2.40
Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum (2009) 2.16
The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am J Respir Crit Care Med (2002) 2.15
Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. J Immunol (1997) 2.10
Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun (2002) 1.99
Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol (2008) 1.93
Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model. FEMS Microbiol Lett (2005) 1.89
Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun (1999) 1.75
Differential requirements for NAIP5 in activation of the NLRC4 inflammasome. Infect Immun (2011) 1.74
A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J Infect Dis (2006) 1.68
Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol (2002) 1.56
Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun (2008) 1.46
Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages. Infect Immun (2008) 1.44
Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect Immun (1997) 1.44
Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci U S A (2004) 1.40
Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc Natl Acad Sci U S A (2009) 1.31
Host-detrimental role of Esx-1-mediated inflammasome activation in mycobacterial infection. PLoS Pathog (2010) 1.31
Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect Immun (2003) 1.10
Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect Immun (2007) 1.07
Never underestimate the power of a neutrophil. Immunity (2009) 1.05
Caspase-1 mediates resistance in murine melioidosis. Infect Immun (2009) 1.04
Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, suppresses bleomycin-induced acute lung injury in mice. Lung (2002) 0.92
IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int J Med Microbiol (2010) 0.91
Interferon-gamma mediates host resistance in a murine model of melioidosis. Biochem Soc Trans (1997) 0.91
Pyroptosis: macrophage suicide exposes hidden invaders. Curr Biol (2011) 0.89
Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis). PLoS Negl Trop Dis (2010) 0.87
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59
Synchrony, waves, and spatial hierarchies in the spread of influenza. Science (2006) 10.43
Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med (2011) 10.29
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med (2009) 8.99
Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med (2005) 8.46
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A (2002) 6.00
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis (2007) 5.91
Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol (2004) 5.26
Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis (2005) 4.75
Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol (2008) 4.60
Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine (2006) 4.28
Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol (2007) 4.06
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis (2012) 3.31
Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg (2006) 3.20
Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol (2007) 3.17
Global influenza seasonality: reconciling patterns across temperate and tropical regions. Environ Health Perspect (2010) 3.09
Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis (2004) 2.80
Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (2009) 2.67
The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol (2007) 2.59
Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog (2007) 2.52
Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med (2011) 2.41
Natality decline and miscarriages associated with the 1918 influenza pandemic: the Scandinavian and United States experiences. J Infect Dis (2011) 2.33
Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog (2008) 2.09
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol (2013) 2.06
Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis (2011) 1.87
Early cement damage around a femoral stem is concentrated at the cement/bone interface. J Biomech (2003) 1.85
Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One (2013) 1.84
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis (2011) 1.83
Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics (2007) 1.79
Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations. J Infect Dis (2010) 1.78
Comparison of PCR and culture for screening of vancomycin-resistant Enterococci: highly disparate results for vanA and vanB. J Clin Microbiol (2009) 1.62
The dilemma of influenza vaccine recommendations when applied to the tropics: the Brazilian case examined under alternative scenarios. PLoS One (2009) 1.57
Clostridium difficile: a formidable foe. CMAJ (2004) 1.54
Geographical distribution and risk factors associated with enteric diseases in Vietnam. Am J Trop Med Hyg (2007) 1.53
Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation. J Leukoc Biol (2006) 1.52
Cutting edge: Necrosis activates the NLRP3 inflammasome. J Immunol (2009) 1.50
Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR) 2/TLR1 heterodimer. J Biol Chem (2007) 1.49
Air travel and the spread of influenza: important caveats. PLoS Med (2006) 1.49
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis (2012) 1.47
Crystal structure of thy1, a thymidylate synthase complementing protein from Thermotoga maritima at 2.25 A resolution. Proteins (2002) 1.45
Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis. Genome Res (2014) 1.40
Early anticoagulation after mechanical valve implantation, and related complications. J Heart Valve Dis (2008) 1.39
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clin Infect Dis (2012) 1.39
Ruptured pulmonary artery aneurysm: a surgical emergency. Asian Cardiovasc Thorac Ann (2011) 1.37
Specific high affinity interactions of monomeric endotoxin.protein complexes with Toll-like receptor 4 ectodomain. J Biol Chem (2006) 1.36
Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of Toll-like receptor 4 by endotoxin. J Biol Chem (2007) 1.36
Spatial and temporal characteristics of the 2009 A/H1N1 influenza pandemic in Peru. PLoS One (2011) 1.35
Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein. FEBS J (2007) 1.35
Experimental micromechanics of the cement-bone interface. J Orthop Res (2008) 1.34
Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling. J Cell Biol (2003) 1.32
Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine (2006) 1.31
Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure. Circulation (2005) 1.27
Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity. Arch Med Res (2012) 1.25
Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine (2009) 1.24
Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS One (2009) 1.24
Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid. Mol Cell (2010) 1.23
1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg Infect Dis (2006) 1.23
Reversible self-assembly of patchy particles into monodisperse icosahedral clusters. J Chem Phys (2007) 1.22
The influence of climatic conditions on the transmission dynamics of the 2009 A/H1N1 influenza pandemic in Chile. BMC Infect Dis (2012) 1.22
Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis (2007) 1.22
Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun (2006) 1.21
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology (2009) 1.21
Creep dominates tensile fatigue damage of the cement-bone interface. J Orthop Res (2004) 1.17
Were equatorial regions less affected by the 2009 influenza pandemic? The Brazilian experience. PLoS One (2012) 1.17
Role of the inflammasome, IL-1β, and IL-18 in bacterial infections. ScientificWorldJournal (2011) 1.15
Transmission potential of influenza A/H7N9, February to May 2013, China. BMC Med (2013) 1.14
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Vaccine (2009) 1.14
Temporal trends and climatic factors associated with bacterial enteric diseases in Vietnam, 1991-2001. Environ Health Perspect (2008) 1.13
Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift. Vaccine (2011) 1.13
Estimating deaths due to influenza and respiratory syncytial virus. JAMA (2003) 1.11
The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol Lett (2007) 1.11
Effect of an educational intervention on optimizing antibiotic prescribing in long-term care facilities. J Am Geriatr Soc (2007) 1.09
The need for interdisciplinary studies of historic pandemics. Vaccine (2011) 1.09
Functional interface micromechanics of 11 en-bloc retrieved cemented femoral hip replacements. Acta Orthop (2010) 1.08
A new approach to quantify trabecular resorption adjacent to cemented knee arthroplasty. J Biomech (2012) 1.07
Shear fatigue micromechanics of the cement-bone interface: An in vitro study using digital image correlation techniques. J Orthop Res (2009) 1.07
The effect of low-viscosity cement on mantle morphology and femoral stem micromotion: a cadaver model with simulated blood flow. Acta Orthop (2006) 1.07
Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection. Clin Infect Dis (2012) 1.04
The Bla2 beta-lactamase from the live-vaccine strain of Francisella tularensis encodes a functional protein that is only active against penicillin-class beta-lactam antibiotics. Arch Microbiol (2006) 1.04
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension. Circulation (2008) 1.04
Comparative dynamics, morbidity and mortality burden of pediatric viral respiratory infections in an equatorial city. Pediatr Infect Dis J (2012) 1.02
Evaluation of Southern Hemisphere influenza vaccine recommendations. Vaccine (2010) 1.02
The 1918-19 influenza pandemic in Boyacá, Colombia. Emerg Infect Dis (2012) 1.02
Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? Vaccine (2005) 1.01
Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc (2013) 1.00
Crystal structure of an iron-containing 1,3-propanediol dehydrogenase (TM0920) from Thermotoga maritima at 1.3 A resolution. Proteins (2004) 1.00
Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity. Eur J Immunol (2007) 1.00
Cement-implant interface gaps explain the poor results of CMW3 for femoral stem fixation: A cadaver study of migration, fatigue and mantle morphology. Acta Orthop (2005) 1.00
Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico. PLoS One (2012) 0.98
Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections. Clin Infect Dis (2011) 0.98
Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza. Proc Natl Acad Sci U S A (2012) 0.98
Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile. J Clin Microbiol (2011) 0.98
An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control. Infect Control Hosp Epidemiol (2006) 0.97
Fluid-structure interactions in micro-interlocked regions of the cement-bone interface. Comput Methods Biomech Biomed Engin (2013) 0.97
Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respir Viruses (2011) 0.97
HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes. Mol Biol Cell (2004) 0.96
Cement microcracks in thin-mantle regions after in vitro fatigue loading. J Arthroplasty (2004) 0.95